ReNeuron Group plc

ReNeuron Group plc (AIM: #RENE) is a clinical-stage stem cell business.

For all investor enquiries please email [email protected]

[Edison @Edison_Inv_Res]

ReNeuron Group — H124 results reaffirm focus on CustomEX. $RENE #AIM @ReNeuronPLC
https://t.co/myJ3BZHUA0

[ReNeuron Group plc @ReNeuronPLC]

ReNeuron announces its unaudited interim results for the six months ended 30 Sept 2023.

Read the full announcement here: https://t.co/NhYwERMoi8

[ReNeuron Group plc @ReNeuronPLC]

ReNeuron announces that Dr Samantha Thomas will be presenting in vivo data exemplifying the cellular and tissue targeting capabilities and highlighting the significant advantages of ReNeuron’s CustomEX™ drug delivery platform, at #Cell2023 in London: https://t.co/Q7A3X6ptWO

[Proactive @proactive_x]

$RENE ReNeuron to showcase drug delivery platform at Cell2023 https://t.co/xJ9CaJallO @reneuronplc $RNUGF #RENE #RNUGF

[Edison @Edison_Inv_Res]

@ReNeuronPLC — A step forward on the Exosome delivery platform. $RENE #AIM
https://t.co/yd7DQkT9Fw

[ReNeuron Group plc @ReNeuronPLC]

ReNeuron announces that it has successfully generated in vivo data to exemplify the cellular and tissue targeting capabilities of exosomes produced from its multiple conditionally immortalised producer cell lines. Read the full announcement here: https://t.co/NhYwERLQsA

[Proactive @proactive_x]

$RENE ReNeuron highlights exosome platform R&D progress https://t.co/lnosvBAE6R @reneuronplc $RNUGF #RENE #RNUGF

[Walbrook PR @WalbrookPR]

ReNeuron Group (AIM: #RENE, @ReNeuronPLC) R&D Update

💼Creating a valuable/differentiated exosome delivery platform
📜in vivo data generated underlines value proposition

🔗https://t.co/2E0NuMz1Zb

[ReNeuron Group plc @ReNeuronPLC]

The Annual Report and Accounts for the year ended 31 March 2023 has today been sent to shareholders and is available to download on the Company’s website here:
https://t.co/0K2QPL2BI9

[Edison @Edison_Inv_Res]

@ReNeuronPLC — Full steam ahead with CustomEx. $RENE #AIM @LSEplc #healthcare #equityresearch https://t.co/Rq1tvM4SgL

[ReNeuron Group plc @ReNeuronPLC]

ReNeuron announces its unaudited preliminary results for the year ended 31 March 2023.

Read the full announcement here:
https://t.co/NhYwERLQsA

#RENE

[Walbrook PR @WalbrookPR]

ReNeuron Group (AIM: #RENE, @ReNeuronPLC) Preliminary results

💰Revenue of £0.5m
💷Cash of £7.2m, runway into 2024
👉Reduced operating costs
👉Reduced loss for the year

🔗https://t.co/oRvr0IgdUO

THREAD⤵️

[Proactive @proactive_x]

$RENE ReNeuron reports increase in revenue after a transitional year https://t.co/j5y8wAVUp4 @reneuronplc $RNUGF #RENE #RNUGF

[ReNeuron Group plc @ReNeuronPLC]

ReNeuron will announce its preliminary results for the year ended 31 March 2023 on Thursday 25 May
Management will also be hosting a live online presentation relating to the results via the @InvestorMeetCo at 9:30am BST on Thursday 25 May 2023. https://t.co/Xq1w6EH1ge

[Investor Meet Company @InvestorMeetCo]

Join RENEURON GROUP PLC's Preliminary Results for the year ended 31 March 2023 on 25th May 2023 at 9:30am BST, Click below to register. #RENE ReNeuronPLC
https://t.co/MfzGeBmNQ2

[Walbrook PR @WalbrookPR]

ReNeuron Group plc (AIM: #RENE, @ReNeuronPLC) Notice of Results

📅Thursday 25 May 2023
🎦Investor presentation via @InvestorMeetCo at 9.30am BST

🔗https://t.co/aIUK1n22lD

[Proactive @proactive_x]

$RENE ReNeuron appoints new scientific advisory board https://t.co/lFfOzpZJEy @reneuronplc $RNUGF #RENE #RNUGF

[ReNeuron Group plc @ReNeuronPLC]

ReNeuron announces the appointment of its newly established Scientific Advisory Board, chaired by Prof. Stefano Pluchino.

Details of the Board members and their bios can be found on the Company website here:
https://t.co/0vHgD9ZPvt

[Walbrook PR @WalbrookPR]

.@ReNeuronPLC announces its newly established Scientific Advisory Board:
👨‍🔬Prof. Giuseppe (Beppe) Battaglia
👩‍🔬Prof. Edit I Buzás
👨‍🔬Prof. Dr. rer. Nat. Bernd Giebel
👨‍🔬Prof. Kenneth W. Witwer
👨‍🔬Prof. Stefano Pluchino (chair)

For more information, https://t.co/YNVslZCcz3

#RENE

[ReNeuron Group plc @ReNeuronPLC]

ReNeuron announces the appointment of @AllenbyCapital as the Company's Nominated Adviser and Sole Broker, with immediate effect.

https://t.co/NhYwERMoi8